CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
HER2, estrogen receptor-negative metastatic hidradenocarcinoma: identification of TP53 mutation in both primary and cell-free DNA
Siho Kim, Jinhyun Cho, Won Park, Sang-Hee Choi, Woongyang Park, Kee-Taek Jang, Jeeyun Lee
Precis Future Med. 2017;1(1):52-57.   Published online March 31, 2017
DOI: https://doi.org/10.23838/pfm.2017.00108

Excel Download

HER2, estrogen receptor-negative metastatic hidradenocarcinoma: identification of TP53 mutation in both primary and cell-free DNA
Precision and Future Medicine. 2017;1(1):52-57   Crossref logo
Link1 Link2 Link3

TP53 mutation and/or overexpression of the HER2 receptor are strong indicators of poor prognosis in both node-negative and node-positive early breast cancer
European Journal of Cancer. 2002;38(11):S107-S108   Crossref logo
Link1 Link2

PR84 FULVESTRANT COMBINED WITH CAPECITABINE MAY BE EFFECTIVE AND WELL TOLERATED FOR PATIENTS WITH ESTROGEN RECEPTOR-POSITIVE, HER2-NEGATIVE METASTATIC BREAST CANCER
The Breast. 2015;24:S50-S51   Crossref logo
Link1 Link2

Ongoing unmet needs in treating estrogen receptor-positive/HER2-negative metastatic breast cancer
Cancer Treatment Reviews. 2018;63:144-155   Crossref logo
Link1 Link2

HER2 genomic amplification in circulating tumor DNA and estrogen receptor positivity predict primary resistance to trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer
Breast Cancer. 2018;25(5):605-613   Crossref logo
Link1 Link2 Link3

TP53 Promoter Methylation in Primary Glioblastoma: Relationship with TP53 mRNA and Protein Expression and Mutation Status
DNA and Cell Biology. 2014;33(4):217-226   Crossref logo
Link1 Link2

Reliability of Her2/neu, estrogen receptor, and progesterone receptor testing by immunohistochemistry on cell block of FNA and serous effusions from patients with primary and metastatic breast carcinoma
Diagnostic Cytopathology. 2011;39(5):328-332   Crossref logo
Link1

TP53 mutations on circulating cell-free DNA
EBioMedicine. 2016;10:15-16   Crossref logo
Link1 Link2

Clinical pattern of primary systemic therapy and outcomes of estrogen receptor-positive, HER2-negative metastatic breast cancer: a review of a single institution
Breast Cancer Research and Treatment. 2017;166(3):911-917   Crossref logo
Link1 Link2 Link3

Somatic mutation analysis of KRAS, BRAF, HER2 and PTEN in EGFR mutation-negative non-small cell lung carcinoma: determination of frequency, distribution pattern and identification of novel deletion in HER2 gene from Indian patients
Medical Oncology. 2016;33(10):   Crossref logo
Link1 Link2 Link3